Locations
Berkeley, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2011
Caribou Biosciences is a clinical-stage biopharmaceutical company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases. Utilizing its proprietary ch RDNA technology, Caribou aims to create off-the-shelf CAR-T cell therapies that enhance activity against diseases through advanced genome editing techniques. The company is positioned as a leader in the CRISPR field, with a strong pipeline targeting hematologic malignancies and autoimmune diseases, and is backed by a team of experts in the biotechnology sector.
Something looks off?